BioPharma Credit (LSE:BPCR) EV-to-Revenue : 5.13 (As of May. 27, 2024)

BioPharma Credit EV-to-Revenue Chart

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
EV-to-Revenue	Get a 7-Day Free Trial							-	14.04	-	6.15	9.12

Competitive Comparison of BioPharma Credit's EV-to-Revenue

For the Asset Management subindustry, BioPharma Credit's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPharma Credit's EV-to-Revenue Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's EV-to-Revenue falls into.

BioPharma Credit EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BioPharma Credit's EV-to-Revenue for today is calculated as:

BioPharma Credit's current Enterprise Value is $945.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioPharma Credit's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was $184.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPharma Credit  (LSE:BPCR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BioPharma Credit's PS Ratiofor today is calculated as:

BioPharma Credit's share price for today is $0.846.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2022 was $0.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioPharma Credit EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description